Diagnostics Market Research Reports & Industry Analysis
The global diagnostics industry plays a critical role in disease prevention, detection, and treatment across a wide range of medical fields—and it’s also a big business with significant opportunities for growth and innovation. As the industry continues to change, staying up to date on the latest trends and insights is essential.
New Diagnostics Industry Reports Produced by Industry Experts
To help organizations understand the market on a deeper level and better navigate the shifting business landscape, MarketResearch.com offers a wide range of diagnostics market research reports. These studies cover both the in vitro diagnostics and medical imaging segments, providing information on market sizing, growth forecasts, market share, mergers and acquisitions, new product development, competitive analysis, and corporate profiling. With coverage of disruptive trends and emerging technologies, our reports give you the knowledge you need to stay ahead of market changes.
What Are the Benefits of Using MarketResearch.com?
- At MarketResearch.com, we understand the value of timely and reliable research. With over 20 years of experience in the field of market research, we have become a leading source of insights and analysis.
- We bring together reports from hundreds of leading firms, making it easy to find the information you need in one place.
- Our knowledgeable research specialists have worked closely with many top diagnostics industry companies and can offer personalized assistance to help you find reports that fit your research requirements.
- With our comprehensive coverage and expert analysis, you will be better positioned to gain a competitive edge in the global diagnostics industry.
Diagnostics Industry Research & Market Reports
-
2024-2028 Heparin-Induced Thrombocytopenia Testing in 90 Countries—Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation
... Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam Europe Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Georgia, ... Read More
-
2024-2028 Global Cannabinoids/Marijuana Testing in 90 Countries—Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation
... Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam Europe Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Georgia, ... Read More
-
2024-2028 Prothrombin Time (PT) Testing in 90 Countries—Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation
... Asia-Pacific Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam Europe Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, ... Read More
-
Global Radiotherapy Market (By Technology, Procedure, Application, End User, Country Analysis), Company Profiles, Market Dynamics, Trends & Recent Developments – Forecast to 2030
... and is predicted to reach US$ 10.27 Billion by 2030. Radiotherapy, also called radiation therapy, is a medical technique used to treat cancer and some non-cancerous conditions. This non-invasive therapy can be administered externally, known ... Read More
-
In-Vitro Colorectal Cancer Screening Tests
... is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 3.4% over the analysis period 2023-2030. Fecal Occult Blood Test, one of the segments analyzed in the report, is expected to record ... Read More
-
Heavy Metal Testing
... by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Arsenic Testing, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$2.1 Billion by ... Read More
-
High-Density Multiplexed Diagnostic Assays
... reach US$5.5 Billion by 2030, growing at a CAGR of 14.8% over the analysis period 2023-2030. Diagnostic Laboratories End-Use, one of the segments analyzed in the report, is expected to record a 15.1% CAGR and ... Read More
-
Human Papillomavirus (HPV) Testing
... reach US$1.8 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2023-2030. Hospitals & Clinics End-Use, one of the segments analyzed in the report, is expected to record a 6.0% CAGR ... Read More
-
Clostridium Diagnostics
... at a CAGR of 14.1% over the analysis period 2023-2030. Immunoassays Technology, one of the segments analyzed in the report, is expected to record a 15.5% CAGR and reach US$9.1 Billion by the end of ... Read More
-
Helicobacter Pylori Diagnostics
... by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$436.9 Million by ... Read More
-
Hybrid Operating Rooms
... by 2030, growing at a CAGR of 12.2% over the analysis period 2023-2030. Cardiovascular Application, one of the segments analyzed in the report, is expected to record a 12.6% CAGR and reach US$1.2 Billion by ... Read More
-
Surgical Imaging Technologies
... by 2030, growing at a CAGR of 2.8% over the analysis period 2023-2030. Image Intensifier C-arms Technology, one of the segments analyzed in the report, is expected to record a 2.7% CAGR and reach US$3.4 ... Read More
-
Teleradiology
... of 17.2% over the analysis period 2023-2030. X-ray, one of the segments analyzed in the report, is expected to record a 15.8% CAGR and reach US$5.2 Billion by the end of the analysis period. Growth ... Read More
-
Flat Panel X-Ray Detectors
... reach US$2.3 Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2023-2030. Manufacturing Application, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach ... Read More
-
X-Ray Photoelectron Spectroscopy
... by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Healthcare End-Use, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$339.2 Million by ... Read More
-
Specimen Validity Testing
... by 2030, growing at a CAGR of 5.1% over the analysis period 2023-2030. Specimen Validity Testing Products, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$2.9 ... Read More
-
Microbiology Culture
... at a CAGR of 3.9% over the analysis period 2023-2030. Eukaryotic Culture, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$5.2 Billion by the end of ... Read More
-
Acute Ischemic Stroke Diagnosis and Treatment
... the year 2023, is expected to reach US$3.1 Billion by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. Computed Tomography, one of the segments analyzed in the report, is expected to ... Read More
-
Coagulation / Hemostasis Analyzers
... reach US$5.0 Billion by 2030, growing at a CAGR of 3.0% over the analysis period 2023-2030. Clinical Laboratory Analyzers, one of the segments analyzed in the report, is expected to record a 2.2% CAGR and ... Read More
-
Multiplex Assays
... at a CAGR of 6.4% over the analysis period 2023-2030. Protein Assays, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$2.5 Billion by the end of ... Read More
-
Multiplex Detection Immunoassays
... by 2030, growing at a CAGR of 3.5% over the analysis period 2023-2030. Disease Testing Application, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$1.5 Billion ... Read More
-
Mycoplasma Testing
... at a CAGR of 8.5% over the analysis period 2023-2030. Mycoplasma Testing Assays, Kits & Reagents, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$940.8 Million ... Read More
-
Non-Invasive Fat Reduction Technologies
... reach US$6.2 Billion by 2030, growing at a CAGR of 15.8% over the analysis period 2023-2030. Cryolipolysis Technology, one of the segments analyzed in the report, is expected to record a 16.6% CAGR and reach ... Read More
-
Nuclear Medicine Radioisotope
... by 2030, growing at a CAGR of 7.7% over the analysis period 2023-2030. Technetium-99m (Tc-99m), one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$11.7 Billion by ... Read More
-
Nucleic Acid Labeling
... by 2030, growing at a CAGR of 7.5% over the analysis period 2023-2030. Nucleic Acid Labeling Reagents, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$2.4 ... Read More
Research Assistance
